Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B

Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B

Published 2 months, 1 week ago
Description
Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 million Series B for its fat-targeted obesity platform, and Sebastian Arana of MilliporeSigma talks through the real cost of manufacturing flexibility.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us